Author(s):
Fadilah Fadilah, Lowilius Wiyono, Brenda Cristie Edina, Risya Amelia Rahmawati, Linda Erlina, Aryo Tedjo, Rafika Indah Paramita
Email(s):
fadilah81@gmail.com
DOI:
10.5958/0974-360X.2019.00400.1 
Address:
Fadilah Fadilah1*,4, Lowilius Wiyono2, Brenda Cristie Edina2, Risya Amelia Rahmawati2, Linda Erlina1, 4, Aryo Tedjo1,3, Rafika Indah Paramita1, 4
1Departement of Medical Chemistry, Faculty of Medicine, University of Indonesia,
2Medical Student of Faculty of Medicine, University of Indonesia,
3Researcher of Drug Development Research Center, Indonesian Medical Education and Research Institute,
Faculty of Medicine, University of Indonesia
4Researcher of Bigdata and Bioinformatics Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, University of Indonesia
*Corresponding Author
Published In:
Volume - 12,
Issue - 5,
Year - 2019
ABSTRACT:
Breast cancer most commonly occurs in women worldwide, in 2012 there were 1.670.000 cases with the second most prevalence in the world (25% of the total incidence of cancer). Drugs used so far have not been effective and many resistance occurs, it is necessary to a discovery of herbs that contain polyphenols as anticancer. Kaempferia pandurata Roxb plant has been identified to contain various essential oils and several flavonoid compounds that have demonstrated many biological activities. This research was done by simulation study with molecular docking approach which then extraction, the result of the extract was tested in vitro activity against Breast Cancer Cell Line MCF-7. The docking results show that the flavonoid compound against the target ER-breast cancer has an enthalpy energy ?G -11.75 kcal/mol, the phytochemical results support that the flavonoids compound dominates the composition of the Kaempferia pandurata Roxb. The Result of in vivo test with MTT method IC50 value of standard cisplatin, hexane extract was 8.42; 26.70 µg/ml respectively to MCF-7 cell line showed that Kaempferia pandurata Roxb extract very potential as an antibreast cancer.
Cite this article:
Fadilah Fadilah, Lowilius Wiyono, Brenda Cristie Edina, Risya Amelia Rahmawati, Linda Erlina, Aryo Tedjo, Rafika Indah Paramita. In Silico Study and In Vitro test of Extract Kaempferia pandurata Roxb. as Anti ER (+) Breast Cancer Cell Line MCF-7. Research J. Pharm. and Tech. 2019; 12(5):2391-2395. doi: 10.5958/0974-360X.2019.00400.1
Cite(Electronic):
Fadilah Fadilah, Lowilius Wiyono, Brenda Cristie Edina, Risya Amelia Rahmawati, Linda Erlina, Aryo Tedjo, Rafika Indah Paramita. In Silico Study and In Vitro test of Extract Kaempferia pandurata Roxb. as Anti ER (+) Breast Cancer Cell Line MCF-7. Research J. Pharm. and Tech. 2019; 12(5):2391-2395. doi: 10.5958/0974-360X.2019.00400.1 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2019-12-5-59